NEWS

08/19/2021

Immunome Reports Second Quarter 2021 Financial Results

07/20/2021

Immunome Antibody Cocktail (IMM-BCP-01) Neutralizes the SARS-CoV-2 Delta Variant in Pre-clinical Testing

07/06/2021

Immunome to Present at the Ladenburg Thalmann 2021 Healthcare Conference

06/30/2021

Immunome Appoints Andrew Badley, M.D., to COVID-19 Advisory Board

06/17/2021

Immunome Appoints Franklyn G. Prendergast, M.D., Ph.D., to Board of Directors

05/27/2021

Immunome to Present at the Jefferies Virtual Healthcare Conference

05/20/2021

Immunome Announces Additional $4.3 Million Award by DOD following Positive Preclinical Testing Results on COVID-19 Variants of Concern

05/12/2021

Immunome Reports First Quarter 2021 Financial Results

04/26/2021

Immunome Announces $27 Million Private Placement

04/26/2021

Immunome SARS-CoV-2 Antibody Cocktail Neutralizes UK, South Africa, Brazil and California Variants in Preclinical Testing; Progressing Towards IND Filing